Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Strojil

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 23, 2019
Gut microbiota metabolizes nabumetone <i>in vitro</i>: Consequences for its bioavailability <i>in vivo</i> in the rodents with altered gut microbiomeLenka Jourova, Pavel Anzenbacher, Zuzana Matuskova, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 11, 2025
Inadequate imipenem dosing in patients with decreased kidney function: a global clinical pharmacokinetic studyAnh Quan Truong, Tim J L Smeets, Jean Terrier, et al.
Pharmaceutics|December 28, 2021
Parametric and Nonparametric Population Pharmacokinetic Models to Assess Probability of Target Attainment of Imipenem Concentrations in Critically Ill PatientsFemke de Velde, Brenda C M de Winter, Michael N Neely, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 23, 2019
Gut microbiota metabolizes nabumetone <i>in vitro</i>: Consequences for its bioavailability <i>in vivo</i> in the rodents with altered gut microbiomeLenka Jourova, Pavel Anzenbacher, Zuzana Matuskova, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 11, 2025
Inadequate imipenem dosing in patients with decreased kidney function: a global clinical pharmacokinetic studyAnh Quan Truong, Tim J L Smeets, Jean Terrier, et al.
Pharmaceutics|December 28, 2021
Parametric and Nonparametric Population Pharmacokinetic Models to Assess Probability of Target Attainment of Imipenem Concentrations in Critically Ill PatientsFemke de Velde, Brenda C M de Winter, Michael N Neely, et al.
Pageof 2